bpc 157 oral bioavailability research BPC-157 BPC-157 – No Proof Required!
Description
While human clinical trials are still needed, the preclinical evidence is compelling
KPV is the most studied for targeted intestinal anti-inflammatory effects
A typical pediatric dose is approximately 0.03 mg per kilogram of body weight (30 g/kg) once daily at bedtime
PMC 8300930
Younger age groups ( 3.0.co;2-h
~ Lisa G.
